BLU-285 FOR UNRESECTABLE, TREATMENT-RESISTANT GASTROINTESTINAL STROMAL TUMORS (GIST)

BLU-285 Presentation by Blueprint Medicines on November 10, 2017 at the CTOS Annual Meeting

BLU-285 Presentation by Blueprint Medicines on June 5, 2017 at the ASCO Annual Meeting

BLU-285 Abstract for Presentation by Blueprint Medicines on June 5, 2017 at the 2017 ASCO Annual Meeting

BLU-285 Abstract for Presentation by Blueprint Medicines on April 5, 2017 at the American Chemical Society Meeting

BLU-285 Presentation by Blueprint Medicines on April 2, 2017 at the AACR Annual Meeting

BLU-285 Presentation by Blueprint Medicines on December 1, 2016 at the EORTC-NCI-AACR Symposium

BLU-285 FOR ADVANCED SYSTEMIC MASTOCYTOSIS (SM)

BLU-285 Plenary Scientific Presentation by Blueprint Medicines on December 10, 2017 at the ASH Annual Meeting

BLU-285 Abstract for Scientific Plenary Presentation by Blueprint Medicines on December 10, 2017 at the ASH Annual Meeting and Exposition

BLU-285 Presentation by Blueprint Medicines on April 2, 2017 at the AACR Annual Meeting

BLU-285 Presentation by Blueprint Medicines on December 4, 2016 at the ASH Annual Meeting and Exposition

 

BLU-554 FOR ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

BLU-554 Presentation on September 17, 2017 at International Liver Cancer Association

BLU-554 Presentation on September 10, 2017 at ESMO 2017 Congress

Abstract for Presentation by Blueprint Medicines Corporation on Sunday, September 17, 2017 at the 11th
International Liver Cancer Association (ILCA) Annual Conference

BLU-554 Abstract for Presentation by Blueprint Medicines on April 5, 2017 at the American Chemical Society Meeting

BLU-554 Poster Presentation by Blueprint Medicines on November 29, 2016 at the EORTC-NCI-AACR Symposium

 

BLU-667 FOR RET-DRIVEN NON-SMALL CELL LUNG CANCER, MEDULLARY THYROID CANCER AND OTHER ADVANCED SOLID TUMORS

BLU-667 Poster Presentation by Blueprint Medicines on October 29, 2017 at the AACR-NCI-EORTC International Conference

BLU-667 Abstract for Poster Presentation by Blueprint Medicines on October 29, 2017 at the AACR-NCI-EORTC International Conference

BLU-667 Presentation by Blueprint Medicines on July 30, 2017 at the World Congress on Thyroid Cancer Meeting

BLU-667 Presentation by Blueprint Medicines on April 18, 2016 at the Annual AACR Meeting